Interfax China - Pharmaceuticals

Wuxi PharmaTech moves towards integration with Nantong plant

Fri, 30 Sep 2011 05:48:45 GMT

Shanghai. September 30. INTERFAX-CHINA - Wuxi PharmaTech Inc., China's largest contract research organization (CRO), will build a contract manufacturing plant in Jiangsu Province's Nantong City, the company announced Sept. 29.

Huadong Medicine eyes acquisition amid growing competition in Zhejiang

Thu, 29 Sep 2011 08:51:27 GMT

Shanghai. September 29. INTERFAX-CHINA - Competition is heating up among Zhejiang's major drug distributors after the biggest player in the province, Huadong Medicine Co. Ltd. (Huadong Medicine), announced plans to increase its holding in a Wenzhou City-based distributor to gain control of the firm.

TCM maker Duyiwei Bio to set up second cultivation unit

Thu, 29 Sep 2011 06:32:39 GMT

Shanghai. September 29. INTERFAX-CHINA - Traditional Chinese medicine (TCM) maker Gansu Duyiwei Biological Pharmaceutical Ltd. (Duyiwei Bio) will set up a second cultivation subsidiary, this time to grow the herb used in its flagship product, an employee told Interfax Sept. 29.

Int'l Pharma to acquire controlling stake in Shaoxing drug distributor

Wed, 28 Sep 2011 09:02:13 GMT

Shanghai. September 28. INTERFAX-CHINA - Zhejiang International Pharmaceutical Co. Ltd. (International Pharma), Zhejiang Province's second largest drug distributor, is to acquire a 50 percent controlling stake in fellow drug distributor Shangyu Medicine Co. Ltd. (Shangyu Medicine) in a bid to shore up its presence in Shaoxing City, International Pharma's parent company announced Sept. 27.

Drug maker Genstar Group up for sale

Tue, 27 Sep 2011 07:09:29 GMT

Shanghai. September 27. INTERFAX-CHINA - Shareholders of Anhui Genstar Group Co. Ltd. (Genstar) have chosen to put the privately-owned drug maker up for sale on the Anhui Assets and Equity Exchange for an asking price of RMB 20 million ($3.13 million), the exchange announced Sept. 26.

Grand Pharma to acquire 81 pct stake in biopesticide producer

Mon, 26 Sep 2011 05:51:14 GMT

Shanghai. September 26. INTERFAX-CHINA - Wuhan City-based China Grand Pharmaceutical & Healthcare Holdings Co. Ltd. (Grand Pharma) has agreed to acquire a major stake in one of China's leading biopesticide producers to secure access to advanced enzyme production technologies, the drug maker announced Sept. 23.

Zhongsheng Pharma inks joint drug R&D deal

Fri, 23 Sep 2011 09:36:21 GMT

Shanghai. September 23. INTERFAX-CHINA - Guangdong Zhongsheng Pharmaceutical Co. Ltd. (Zhongsheng Pharma), a drug research firm based in Guangdong Province's Dongguan City, has agreed to develop three drugs in collaboration with Sichuan University and the South China Center for Innovative Pharmaceuticals (SCCIP), the firm announced Sept. 23.

TCM maker Kanion Pharma to sell off stake in health product firm

Fri, 23 Sep 2011 07:26:07 GMT

Shanghai. September 23. INTERFAX-CHINA - Traditional Chinese medicine (TCM) maker Jiangsu Kanion Pharmaceutical Co. Ltd. (Kanion Pharma) has agreed to sell off its majority stake in a health product trading firm to refocus on its core production business, an employee told Interfax Sept. 23.

Tech-Bank secures production approval for blue-ear pig vaccine

Thu, 22 Sep 2011 09:21:28 GMT

Shanghai. September 22. INTERFAX-CHINA - Leading domestic animal feed producer Ningbo Tech-bank Co. Ltd. (Tech-Bank) has obtained production approval from the Ministry of Agriculture (MoA) for a live vaccine for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), the company announced Sept. 21.

Bio startup Hua Medicine secures $50 mln funding

Wed, 21 Sep 2011 09:56:38 GMT

Shanghai. September 21. INTERFAX-CHINA - Biotechnology startup Hua Medicine has raised $50 million in second-round funding from a group of health care investors in China and U.S., the Shanghai-based firm announced Sept. 20.

TCM watchdog unveils development plan for Hainan Province

Wed, 21 Sep 2011 06:23:35 GMT

Shanghai. September 20. INTERFAX-CHINA - The State Administration of Traditional Chinese Medicine (SATCM), China's TCM industry watchdog, has agreed to work with authorities in south China's Hainan Province to promote the local TCM sector during the 12th Five-Year Plan (2011-2015), the SATCM announced Sept. 18.

Hitachi Medical breaks ground on Suzhou plant

Tue, 20 Sep 2011 08:23:11 GMT

Shanghai. September 20. INTERFAX-CHINA - Hitachi Medical System (Suzhou) Corp., a unit of Japanese medical device maker Hitachi Medical Corp., has started construction of a second plant in Jiangsu Province's Suzhou City, a company representative told Interfax Sept. 20.

Lingrui Pharma plans private placement to fund relocation, expansion

Mon, 19 Sep 2011 08:41:50 GMT

Shanghai. September 19. INTERFAX-CHINA - Traditional Chinese medicine (TCM) maker Henan Lingrui Pharmaceutical Co. Ltd. (Lingrui Pharma) hopes to raise RMB 386 million ($15.67 million) in a private placement to fund the relocation and expansion of its main production plant for oral drugs, an employee told Interfax Sept. 19.

Hengrui Medicine partners with Shanghai CRO for mAb R&D

Fri, 16 Sep 2011 08:36:45 GMT

Shanghai. September 16. INTERFAX-CHINA - Jiangsu Hengrui Medicine Co. Ltd. (Hengrui Medicine), China's leading manufacturer of oncology drugs, has entered a collaborative agreement with China's second largest contract research organization (CRO), ShangPharma Corp., to develop novel therapeutic monoclonal antibodies (mAbs), ShangPharma announced Sept. 15.

Hepalink to inject $12 mln into HK unit

Fri, 16 Sep 2011 04:53:01 GMT

Shanghai. September 16. INTERFAX-CHINA - Shenzhen Hepalink Pharmaceutical Co. Ltd. (Hepalink), China's largest producer of heparin sodium active pharmaceutical ingredient (API), plans to inject HKD 95 million ($12.18 million) into its wholly-owned Hong Kong subsidiary and develop it into a platform for overseas expansion, the company announced Sept. 14.

Survey shows surging demand for TCM care

Thu, 15 Sep 2011 09:17:18 GMT

Shanghai. September 15. INTERFAX-CHINA - China is witnessing surging demand for traditional Chinese medicine (TCM) health care, with outpatient visits to TCM hospitals rocketing by 68 percent in the past decade to reach 320 million last year, up from 190 million in 2001, according to the results of an official survey released Sept. 15.

Merck embarks on biomarker project with China genome institute

Wed, 14 Sep 2011 10:23:10 GMT

Shanghai. September 14. INTERFAX-CHINA - Merck & Co. Inc. has signed a collaborative agreement with the Beijing Genomics Institute (BGI), a leading privately-owned genome research institute in China, on a project to discover and develop biomarkers and genome technology, the U.S. pharmaceutical giant announced Sept. 13.

Wanbei Pharma clinches EU GMP for antibiotic API

Wed, 14 Sep 2011 05:55:43 GMT

Shanghai. September 14. INTERFAX-CHINA - Privately held antibiotic producer Anhui Wanbei Pharmaceutical Co. Ltd. (Wanbei Pharma) has won European Union (EU) Good Manufacturing Practice (GMP) certification for lincomycin hydrochloride active pharmaceutical ingredient (API), opening the door for exports to Europe, the firm announced Sept. 13.

MicroPort to acquire orthopedic implant maker

Tue, 13 Sep 2011 07:49:31 GMT

Shanghai. September 13. INTERFAX-CHINA - MicroPort Scientific Corp. (MicroPort), a leading vascular device maker in China, will strengthen its orthopedics operations with the acquisition of a Suzhou City-based producer and distributor of orthopedic implants, the firm announced Sept. 9.

Honz Pharma to buy antibiotic injection rights for $11 mln

Fri, 09 Sep 2011 09:27:36 GMT

Shanghai. September 9. INTERFAX-CHINA - Honz Pharmaceutical Co. Ltd. (Honz Pharma), a manufacturer of pediatric drugs in China, plans to purchase the rights and production technology for an exclusive antibacterial injection from Hainan Guoruitang Pharmaceutical Co. Ltd. (Guoruitang) for RMB 73 million ($11.44 million), Honz Pharma announced Sept. 7.

Health reform helps maintain momentum in medical device sector

Fri, 09 Sep 2011 08:00:41 GMT

Shanghai. September 8. INTERFAX-CHINA - China's medical device makers continued to see strong profit growth in the first half (H1) this year, bucking a trend for shrinking margins in the wider pharmaceutical industry, an analyst told Interfax Sept. 7.

Arrail Dental secures $20 mln in second-round funding

Thu, 08 Sep 2011 10:14:26 GMT

Shanghai. September 8. INTERFAX-CHINA - Arrail Dental International Group Co. Ltd., a leading provider of high-end dental services in China, has raised $20 million in its second round of funding, a representative of the firm told Interfax Sept. 8.

Fosun Pharma forms generics JV with Swiss API maker

Wed, 07 Sep 2011 08:16:51 GMT

Shanghai. September 7. INTERFAX-CHINA - Shanghai Fosun Pharmaceutical (Group) Co. Ltd., a leading drug maker in China, has agreed to form a 50:50 generics joint venture (JV) with Swiss active pharmaceutical ingredient (API) producer Lonza Group AG, a Fosun Pharma manager told Interfax Sept. 7.

Excipient maker Er-Kang Pharma gets nod for Shenzhen GEM IPO

Wed, 07 Sep 2011 06:27:46 GMT

Shanghai. September 6. INTERFAX-CHINA - Hunan Er-Kang Pharmaceutical Co. Ltd., a leading producer of pharmaceutical excipients, has received approval to launch an initial public offering (IPO) to raise up to RMB 500.46 million ($78.37 million) on the Shenzhen Stock Exchange Growth Enterprise Market (GEM), the company announced Sept. 6.

China launches rehab medicine pilot program

Tue, 06 Sep 2011 07:20:24 GMT

Shanghai. September 6. INTERFAX-CHINA - China has launched a pilot program to expand and integrate rehabilitation medicine services in its health care system in a bid to meet growing needs for chronic disease therapy among its rapidly aging population, the Ministry of Health (MoH) announced Sept. 2.